Biggest News Aggregation in the World
📰 Assembly Bioscience News

Assembly Bioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Assembly Bioscience. Real-time updates on events, politics, business and more.

Assembly Biosciences' (ASMB) Neutral Rating Reiterated at HC Wainwright

HC Wainwright reissued their neutral rating on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a research note issued to investors on Monday, Benzinga reports. HC Wainwright also issued estimates for Assembly Biosciences’ Q1 2024 earnings at ($2.74) EPS, Q2 2024 earnings at ($2.96) EPS, Q3 2024 earnings at ($3.29) EPS, Q4 2024 earnings […]
United States Alexander Schornstein Assembly Bioscience Insider Activity At Assembly Biosciences Acuitas Investments Marquette Asset Management

Assembly Biosciences, Inc. (NASDAQ:ASMB) Expected to Post Earnings of -$0.54 Per Share

Wall Street brokerages forecast that Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Rating) will report earnings per share of ($0.54) for the current quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Assembly Biosciences’ earnings. The lowest EPS estimate is ($0.57) and the highest is ($0.51). Assembly Biosciences reported earnings of ($0.55) per share […]
United States Assembly Biosciences Assembly Biosciences Inc Zacks Investment Research Blackrock Inc Assembly Bioscience

Comparing Gemini Therapeutics (NASDAQ:GMTX) and Assembly Biosciences (NASDAQ:ASMB)

Gemini Therapeutics (NASDAQ:GMTX – Get Rating) and Assembly Biosciences (NASDAQ:ASMB – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, analyst recommendations and institutional ownership. Earnings & Valuation This table compares Gemini Therapeutics and […]
United States United Kingdom South San Francisco Assembly Biosciences Arbutus Biopharma Corporation Door Pharmaceuticals

Zacks: Analysts Anticipate Assembly Biosciences, Inc. (NASDAQ:ASMB) to Announce -$0.49 EPS

Analysts expect Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Rating) to announce earnings per share of ($0.49) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Assembly Biosciences’ earnings. The highest EPS estimate is ($0.35) and the lowest is ($0.56). Assembly Biosciences posted earnings per share of ($0.69) in the same quarter […]
United States Thomson Reuter Assembly Biosciences Assembly Biosciences Inc Zacks Investment Research Indexiq Advisors

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Brokerages Anticipate Assembly Biosciences, Inc. (NASDAQ:ASMB) to Announce -$0.47 Earnings Per Share

Wall Street analysts expect that Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Rating) will announce earnings per share (EPS) of ($0.47) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Assembly Biosciences’ earnings, with the lowest EPS estimate coming in at ($0.59) and the highest estimate coming in at […]
Assembly Biosciences Virtu Financial Assembly Biosciences Inc Zacks Investment Research Assembly Bioscience Assembly Biosciences Get Rating

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science